Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Published on by Shen Awards

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

  1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    • Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
    • Year: 2024
    • Journal: Acta Neuropathologica
    • Volume: 148(1), Pages 2
  2. Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
    • Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
    • Year: 2024
    • Journal: Journal of Immunological Methods
    • Volume: 534, Article 113747
  3. Prion Protein: The Molecule of Many Forms and Faces
    • Authors: Kovač, V., Šerbec, V.Č.
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
    • Volume: 23(3), Article 1232
    • Citations: 21
  4. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
    • Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
    • Year: 2021
    • Journal: Journal of Allergy and Clinical Immunology
    • Volume: 148(2), Pages 621–626.e7
    • Citations: 36
  5. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
    • Authors: Kovač, V., Čurin Šerbec, V.
    • Year: 2018
    • Journal: Biomarker Insights
    • Volume: 13
    • Citations: 6
  6. Targeting malignant brain tumors with antibodies
    • Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
    • Year: 2017
    • Journal: Frontiers in Immunology
    • Volume: 8(SEP), Article 1181
    • Citations: 57
  7. Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
    • Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
    • Year: 2017
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 484(1), Pages 45–50
    • Citations: 10
  8. New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    • Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
    • Year: 2017
    • Journal: Zdravniski Vestnik
    • Volume: 86(5-6), Pages 177–184
  9. Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
    • Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
    • Year: 2016
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 481(1-2), Pages 1–6
    • Citations: 10
  10. Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
    • Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
    • Year: 2016
    • Journal: Molecules
    • Volume: 21(10), Article 1300
    • Citations: 9

 

 

Raza Ullah Asif | Microbiology | Best Researcher Award

Published on by Shen Awards

Dr. Raza Ullah Asif | Microbiology | Best Researcher Award

Virologist at Armed Forces Institute of Pathology (AFIP), Pakistan.

Raza Ullah Asif is a dedicated medical professional specializing in pathology and virology. With a solid educational foundation, including an MBBS from the Army Medical College in Rawalpindi, he is currently pursuing further specialization through a FCPS in Virology. Raza has garnered extensive clinical experience, having worked as a general practitioner and now as a resident trainee in virology at the Armed Forces Institute of Pathology (AFIP). His active involvement in research, highlighted by presentations at prominent conferences and publications in medical journals, showcases his commitment to advancing medical knowledge. He also contributes to the scientific community as a reviewer for several medical journals. Raza’s passion for research, coupled with his clinical expertise, positions him as a promising figure in the field of pathology and virology.

Professional Profile

Education

Raza Ullah Asif obtained his MBBS degree in November 2013 from the Army Medical College, affiliated with the National University of Science and Technology (NUST) in Islamabad. Currently, he is pursuing a Diploma in Grading in Pathology at the Armed Forces Post Graduate Medical Institute (AFPGMI) in Rawalpindi, expected to complete in July 2024. Furthermore, he is in training for his Fellowship of the College of Physicians and Surgeons Pakistan (FCPS) in Virology, which commenced in July 2024. This continuous pursuit of advanced education demonstrates Raza’s commitment to developing his expertise and ensuring he stays updated with the latest advancements in medical science, particularly in pathology and virology.

Professional Experience

Raza Ullah Asif has accumulated valuable clinical experience since graduating from medical school. He completed a house job in Medicine and Surgery at Combined Military Hospital, Jhelum, from May 2014 to May 2015. Following this, he served as a General Practitioner from May 2015 to September 2018 and then transitioned to a Family Medicine Department role at Prince Sultan Military Medical City in Riyadh, Saudi Arabia, until July 2022. Currently, he is undergoing training in pathology and virology at AFIP, Rawalpindi. His diverse clinical roles have equipped him with practical skills in patient management, diagnostics, and treatment, thereby enriching his understanding of medical practice.

Research Interests

Raza Ullah Asif’s research interests primarily focus on the fields of virology and pathology. He has a particular interest in studying viral infections, their mechanisms of transmission, and implications for public health. His recent research work includes evaluating new onset BK viruria in post-renal transplant recipients and genomic characterization of the Crimean Congo Hemorrhagic Fever virus. These projects reflect his commitment to understanding infectious diseases and their impact on patient outcomes. Additionally, Raza is keen on exploring advancements in diagnostic techniques and contributing to the development of effective treatment protocols, highlighting his dedication to improving healthcare through research.

Research Skills

Raza Ullah Asif possesses a robust skill set in research methodology, biostatistics, and medical writing, honed through workshops and practical experiences. He is proficient in quantitative PCR techniques, which are essential for viral detection and analysis. His experience in preparing and presenting research findings at national conferences demonstrates his ability to communicate complex information effectively. Raza’s involvement as a reviewer for medical journals indicates his analytical skills and critical thinking in evaluating scientific literature. His continuous pursuit of knowledge in research methodology ensures he remains adept at employing innovative techniques in his investigations, reinforcing his commitment to advancing medical research.

Awards and Honors

While Raza Ullah Asif’s curriculum vitae does not explicitly list specific awards or honors, his active participation in professional conferences and workshops reflects his recognition within the medical community. His presentations at the 44th and 45th Annual Pakistan Association of Pathologists (PAP) Conferences indicate his emerging reputation as a researcher in pathology and virology. Additionally, serving as a reviewer for esteemed medical journals showcases the trust placed in his expertise by his peers. As he progresses in his training and research, Raza is likely to achieve further recognition, and it is anticipated that his future contributions will merit acknowledgment and accolades within the medical research field.

Conclusion:

Raza Ullah Asif is a promising candidate for the Best Researcher Award, particularly due to his strong foundation in clinical virology, active engagement in research, and experience as a reviewer. His focus on relevant and impactful research topics, such as BK viruria in post-transplant patients and viral genomics, positions him as a valuable contributor to the field of pathology and virology. To further strengthen his candidacy, he could benefit from expanding his research output and engaging in more international collaborations. Nevertheless, his achievements thus far demonstrate a clear dedication to advancing medical research and make him a deserving nominee for the award.

Publications Top Notes

  • Evaluation of new-onset BK viruria in post-renal transplant recipients by quantitative PCR
  • Authors: RU Asif, E Ghani, MA Rathore, S Mushtaq, F Ahmed, H Hussain
  • Journal: Transplant Immunology
  • Year: 2024

 

 

 

 

Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Published on by Shen Awards

Prof. Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Associate Professor at Chungnam National University/College of Pharmacy, South Korea

Dr. Han Young Chung is an accomplished Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. With a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University, Dr. Chung has an extensive background in gastroenterology research, having completed post-doctoral fellowships at The University of Michigan and Seoul National University. He has received multiple honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and several prestigious scholarships. Dr. Chung has successfully secured research funding, notably leading a Creative Challenge Project funded by the National Research Foundation of Korea. His prolific publication record includes numerous articles in high-impact journals, focusing on food safety and pathogenic microorganisms. He has also presented his research internationally, contributing to advancements in understanding microbial interactions and pathogenesis. Dr. Chung’s dedication to research and teaching makes him a strong candidate for the Best Researcher Award.

Profile

Education

Dr. Han Young Chung has an impressive educational background that underpins his expertise in the field of molecular microbiology and toxicology. He completed his Bachelor’s degree in Biotechnology and Bioinformatics, graduating cum laude from Korea University in 2013, where he achieved an overall GPA of 4.4/4.5. Following this, he pursued his Ph.D. at Seoul National University, where he specialized in Molecular Microbiology and Toxicology. Dr. Chung excelled in his studies, earning a remarkable overall GPA of 4.11/4.3 while completing 60 credits from September 2013 to August 2020. After obtaining his doctorate, he enhanced his research experience as a Post-Doctoral Fellow at the University of Michigan Medical School from September 2022 to February 2024 and previously at the Center for Food and Bioconvergence at Seoul National University. His educational journey reflects a strong foundation in scientific research and dedication to advancing knowledge in his field.

Professional Experience

Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education.

Research Interest

Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis.

Research Skills

Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field.

Award and Recognition

Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award.

Conclusion

Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field.

Publication Top Notes
  • Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke
    • Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae
    • Year: 2013
    • Journal: Toxicological Research
    • Volume/Issue/Page: 29, 157-164
  • Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management
    • Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim
    • Year: 2016
    • Journal: International Journal of Food Microbiology
    • Volume/Issue/Page: 234, 45-52
  • Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak
    • Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi
    • Year: 2021
    • Journal: Food Microbiology
    • Volume/Issue/Page: 93, 103602
  • Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography …
    • Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, …
    • Year: 2012
    • Journal: Journal of Chromatography B
    • Volume/Issue/Page: 897, 55-63
  • Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats
    • Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae
    • Year: 2022
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 19(1), 60
  • Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells
    • Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi
    • Year: 2021
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 18, 1-12
  • Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine
    • Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, …
    • Year: 2013
    • Journal: Thrombosis Research
    • Volume/Issue/Page: 131(3), 254-261
  • Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad
    • Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish
    • Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013
    • Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim
    • Year: 2017
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 9, 1-8

 

 

Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Published on by Shen Awards

Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Supervisor of Islamic Azad University, Iran.

Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field.

Profile
Education

Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.

Professional Experience

Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.

Research Interest

Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.

Research Skills

Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development.

Awards and Recognition

Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community.

Conclusion

Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology.

Publications Top Notes

  • Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells
    • Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri
    • Year: 2024
  • Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2024
  • Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection
    • Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh
    • Year: 2024
    • Citations: 1
  • Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans
    • Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami
    • Year: 2023
    • Citations: 1
  • Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 3
  • Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans
    • Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 1
  • Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene
    • Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi
    • Year: 2022
  • Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance
    • Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2021
    • Citations: 2
  • Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans
    • Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri
    • Year: 2021
    • Citations: 15
  • Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
    • Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis
    • Year: 2021
    • Citations: 28